Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q4 2025 Earnings Call Transcript January 28, 2026Teva Pharmaceutical Industries Limited beats earnings expectations. Operator: Hello, and welcome to the Teva Pharmaceuticals Industries Limited Q4 2025 Earnings Conference Call. And that’s really what people need in ulcerative colitis and Crohn’s disease. But it’s probably a bit surprising for people to see just the quality of the pipeline that’s emerged in such a short space of time. I think that’s baked into every one of our programs at this point.